Atlas Trials

Stage IV Lymphoepithelioma of the Nasopharynx

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Lymphoepithelioma of the Nasopharynx

RecordFirmDate
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy (NCT02123511)Mayo Clinic2014-04-01
Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer (NCT01254734)City of Hope Medical Center2011-04-01
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer (NCT01155609)University of Washington2010-09-01
Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC) (NCT00896181)Stanford University2008-12-10
Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer (NCT01637194)Fox Chase Cancer Center2008-11-01
Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer (NCT00454142)National Cancer Institute (NCI)2007-08-01
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer (NCT00492089)National Cancer Institute (NCI)2007-06-01
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384)National Cancer Institute (NCI)2007-01-01
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer (NCT00101348)National Cancer Institute (NCI)2005-01-01
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00089362)National Cancer Institute (NCI)2004-07-01
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer (NCT00068497)National Cancer Institute (NCI)2003-08-01
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681)National Cancer Institute (NCI)2001-12-01
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498)National Cancer Institute (NCI)2001-12-01
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer (NCT00023959)National Cancer Institute (NCI)2001-07-01

Track Stage IV Lymphoepithelioma of the Nasopharynx automatically

Every clearance here is in the API, with alerts when new ones post.